Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence?
Marchioni M, Amparore D, Marandino L, Bertolo R, Erdem S, Ingels A, Muselaers S, Kara O, Pavan N, Roussel E, Carbonara U, Pecoraro A, Diana P, Pecoraro A, Campi R; European Association of Urology Young Academic Urologists Renal Cancer Working Group.
Marchioni M, et al. Among authors: bertolo r.
Eur Urol Open Sci. 2022 Oct 25;46:39-42. doi: 10.1016/j.euros.2022.10.002. eCollection 2022 Dec.
Eur Urol Open Sci. 2022.
PMID: 36325369
Free PMC article.
No abstract available.